Sands Capital Announces $555 Million Close of Life Sciences Pulse Fund III
May 14 2024 - 8:01AM
Business Wire
Fund partners with private companies helping
transform how diseases are defined, diagnosed, and treated
Sands Capital, an active, long-term investor in leading
innovative businesses globally, today announced the close of its
third life sciences fund, Sands Capital Life Sciences Pulse Fund
III (“Pulse III”), raising $555 million. Pulse III was met with
high demand from both existing and new limited partners. This close
increases total Pulse strategy capital commitments to $1.3 billion,
including Sands Capital Life Sciences Pulse Fund (“Pulse I”) and
Sands Capital Life Sciences Pulse Fund II (“Pulse II”). The team
will continue investing with the same emphasis on private
therapeutics, diagnostics, medical devices, and life sciences tools
businesses, in support of the strategy’s mission to help transform
how diseases are defined, diagnosed, and treated.
“The life sciences sector continues to innovate at a rapid pace,
leading to breakthroughs that benefit both patients and society as
a whole,” said Stephen Zachary, Managing Partner. “We are grateful
to both the investors joining us in Pulse III and the talented
management teams we’ve partnered with since the strategy’s
inception.”
The Pulse investment team comprises senior professionals led by
founders, operators, PhDs, and experienced investors with the
ability to leverage the resources and capabilities of the entire
firm to execute its strategy. The team also draws upon Sands
Capital’s more than three decades of deep research and experience
investing in innovation in public markets.
As of March 31, 2024, Sands Capital managed over $54 billion in
public and private equity investments including more than $5
billion in life sciences and health care companies globally across
all strategies.
About Sands Capital
Sands Capital is an active, long-term investor in leading
innovative businesses globally. Our approach combines analytical
rigor and creative thinking to identify high-quality growth
businesses that are creating the future. Through an integrated
investment platform spanning venture capital, private growth equity
and public growth equity, we provide growth capital solutions to
institutions and fund sponsors in more than 40 countries. Sands
Capital is an independent, staff-owned firm founded in 1992 with
offices in the Washington, D.C. area, San Francisco, London, and
Singapore. www.sandscapital.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240514476098/en/
Chaneigh Bernard pro-sandscapital@prosek.com